Replies to post #103835 on Avid Bioservices Inc (CDMO)

[md1225]

The trial is contiuing Peregrine updated "clinical trials.gov" last thursday. They actually updated some coding discrepancies....


Peregrine has 3 phase 2 trials with data points to be read out soon.

They will NEVER do another phase 2b again!

They could go to the FDA and have a phase 3 trial design approved for pancreatic cancer.

This is it boys "Big pharma" has seen it and if they want it we will know in the next few months..

If not Im OUT!

[geocappy1]

Is there any chance the delay could be due to the FDA saying we need more support to allow the 2nd line lung to move to phase III (political cover) and when the 1st line lung and pancreatic MOS data comes in we will use it to prop up the flawed 2nd line lung data when we allow it to move forward.

IMO whatever the situation is must involve something that they can't make public regardless if it is good or bad. If good, it could be as simple as above. If bad, could it be they want to keep the pps above $1 Gil after Monday. I hope this is not the case for many reasons.

For me, it is hard to believe Garnick can't get the FDA to go along with the patients in the 2nd line lung must be living because Bavi is at least effective and deserves to move forward. Maybe the FDA said lets wait until we get more MOS data from the other trials.

Who knows?

[flsh66]

a refreshing assessment - thanks for the contribution

[co3aii]

nuke661, are you USNA? When did you serve on the Lapon?

The game should be close. If Army's defense holds up they win, their offense has been excellent so look for ball control to be key.

Regarding AF, this is the first time I have ever seen, after very many years of biotech investing, that an FDA Phase III go ahead approval was seen as a negative. Things must be desperate at theStreet, too bad.....